share_log

Guggenheim Capital LLC Increases Position in UiPath Inc. (NYSE:PATH)

Guggenheim Capital LLC Increases Position in UiPath Inc. (NYSE:PATH)

古根海姆資本有限責任公司增加 UiPath 公司(紐約證券交易所代碼:PATH)的地位
Defense World ·  2023/03/09 19:05

Guggenheim Capital LLC increased its position in shares of UiPath Inc. (NYSE:PATH – Get Rating) by 18.8% in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 63,663 shares of the healthcare company's stock after purchasing an additional 10,062 shares during the period. Guggenheim Capital LLC's holdings in UiPath were worth $803,000 as of its most recent SEC filing.

根據其最近與證券交易委員會的披露,古根海姆資本有限責任公司在 UiPath Inc.(紐約證券交易所代碼:PATH — 獲得評級)第三季度增加了 18.8% 的股份地位。機構投資者在期間額外購買 10,062 股股票後,擁有該醫療保健公司股票的 63,663 股。根據其最近的 SEC 備案,古根海姆資本有限責任公司在 UiPath 的持股價值為 803,000 美元。

Several other large investors have also recently added to or reduced their stakes in the company. SeaCrest Wealth Management LLC acquired a new stake in UiPath during the second quarter worth approximately $25,000. Householder Group Estate & Retirement Specialist LLC purchased a new position in shares of UiPath in the 3rd quarter valued at $25,000. Edmond DE Rothschild Holding S.A. purchased a new position in shares of UiPath in the 2nd quarter valued at $59,000. American International Group Inc. purchased a new stake in UiPath during the 2nd quarter worth $74,000. Finally, SRS Capital Advisors Inc. increased its stake in UiPath by 110.0% during the 2nd quarter. SRS Capital Advisors Inc. now owns 4,636 shares of the healthcare company's stock worth $84,000 after buying an additional 2,428 shares during the period. 56.40% of the stock is owned by hedge funds and other institutional investors.

其他一些大型投資者最近也增加或減少了他們在公司的股份。西克雷斯特財富管理有限責任公司在第二季度收購了 UiPath 的新股份,價值約為 25,000 美元。住戶集團遺產與退休專家有限責任公司在第三季度購買了 UiPath 股份的新職位,價值為 25,000 美元。愛德蒙德羅斯柴爾德控股有限公司在第二季度購買了價值 59,000 美元的 UiPath 股份的新頭寸。美國國際集團公司在第二季度購買了價值 74,000 美元的 UiPath 的新股份。最後,在第二季度,SRS 資本顧問公司將其在 UiPath 的股份增加了 110.0%。在此期間,SRS 資本顧問公司現在擁有該醫療保健公司股票的 4,636 股,價值 84,000 美元。56.40% 的股票由對沖基金和其他機構投資者擁有。

Get
取得
UiPath
UiPath
alerts:
警報:

UiPath Trading Up 1.1 %

交易指數上漲 1.1%

Shares of NYSE:PATH opened at $15.44 on Thursday. UiPath Inc. has a fifty-two week low of $10.40 and a fifty-two week high of $31.88. The company's 50-day moving average price is $14.66 and its 200 day moving average price is $13.69.

紐約證券交易所股票代碼:PATH 週四以 15.44 美元開盤。UiPath 公司擁有五十兩周低點 10.40 美元,創下五十二周高點 31.88 美元。該公司的 50 天移動平均價格為 14.66 美元,其 200 日移動平均價格為 13.69 美元。

Insiders Place Their Bets

內部人士下注

In other UiPath news, CFO Ashim Gupta sold 40,000 shares of the business's stock in a transaction dated Wednesday, February 15th. The shares were sold at an average price of $16.61, for a total transaction of $664,400.00. Following the sale, the chief financial officer now directly owns 1,359,051 shares in the company, valued at approximately $22,573,837.11. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. 31.88% of the stock is owned by insiders.

在其他 UiPath 新聞中,首席財務官阿希姆·古普塔在 2 月 15 日(星期三)的交易中出售了 40,000 股該業務的股票。這些股票以 16.61 美元的平均價格出售,總交易金額為 664,400.00 美元。出售後,首席財務官現在直接擁有該公司 1,359,051 股股份,價值約為 22,573,837.11 美元。該交易在與證券交易委員會的法律文件中披露,可以通過以下方式訪問 這個鏈接。31.88% 的股票由內部人士擁有。

Wall Street Analyst Weigh In

華爾街分析師稱重

PATH has been the topic of several analyst reports. Evercore ISI dropped their price target on shares of UiPath to $17.00 in a research note on Friday, December 2nd. JPMorgan Chase & Co. decreased their price objective on shares of UiPath from $18.00 to $16.00 and set a "neutral" rating for the company in a report on Friday, December 2nd. Barclays decreased their price objective on shares of UiPath from $15.00 to $13.00 and set an "equal weight" rating for the company in a report on Tuesday, January 10th. Truist Financial decreased their price objective on shares of UiPath from $25.00 to $20.00 and set a "buy" rating for the company in a report on Friday, December 2nd. Finally, Royal Bank of Canada decreased their price objective on shares of UiPath from $16.00 to $15.00 and set a "sector perform" rating for the company in a report on Monday, November 28th. Nine equities research analysts have rated the stock with a hold rating and six have given a buy rating to the company. According to data from MarketBeat.com, UiPath currently has an average rating of "Hold" and a consensus price target of $17.97.

PATH 一直是幾個分析師報告的主題。永可 ISI 在 12 月 2 日(星期五)的一份研究報告中將 UiPath 股票的價格目標降至 17.00 美元。摩根大通公司在 12 月 2 日(星期五)的一份報告中,摩根大通公司對 UiPath 股票的價格目標從 18.00 美元降至 16.00 美元,並為該公司設定了「中立」評級。巴克萊公司將 UiPath 股票的價格目標從 15.00 美元降至 13.00 美元,並在 1 月 10 日(星期二)的一份報告中為該公司設定了「同等權重」評級。誠信金融將其對 UiPath 股票的價格目標從 25.00 美元降至 20.00 美元,並在 12 月 2 日(星期五)的一份報告中為該公司設定了「買入」評級。最後,加拿大皇家銀行將 UiPath 股票的價格目標從 16.00 美元降至 15.00 美元,並在 11 月 28 日星期一的報告中為該公司設定了「行業表現」評級。九位股票研究分析師對該股票進行了持有評級,其中六名股票給予該公司的買入評級。根據來自 MarketBeat.com 的數據,UiPath 目前的平均評級為「持有」,共識價格目標為 17.97 美元。

UiPath Profile

使用路徑設定檔

(Get Rating)

(取得評分)

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, and Japan. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.

UiPath Inc 提供端到端自動化平台,主要在美國,羅馬尼亞和日本提供一系列機器人流程自動化(RPA)解決方案。該公司提供一套相互關聯的軟體,用於建置、管理、執行、參與、測量和控管組織內的自動化。

Further Reading

進一步閱讀

  • Get a free copy of the StockNews.com research report on UiPath (PATH)
  • META Platforms May See its Biggest Opening Yet for New Highs
  • Penny Stock Vinco Ventures Could Be Big Winner
  • Is Chip Design Specialist Synopsys A Gem Hiding In Plain Sight?
  • Should You Park Some Capital with Casey's General Stores?
  • Crowdstrike Stock: While The Iron Is Hot!
  • 獲取有關 UiPath(路徑)的研究報告的免費副本
  • META 平台可能會看到迄今為止最大的開盤新高
  • 竹篙股票域高企業可能是大贏家
  • 芯片設計專家新思科技是隱藏在眼前的寶石嗎?
  • 你應該停放一些資本與凱西的綜合商店?
  • 群眾罷工股票:雖然鐵是熱的!

Receive News & Ratings for UiPath Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UiPath and related companies with MarketBeat.com's FREE daily email newsletter.

接收 UiPath 每日新聞和評分 -在下面輸入您的電子郵件地址,以通過 MarketBeat.com 的免費每日電子郵件通訊接收 UiPath 和相關公司的最新新聞和分析師評級的簡明每日摘要。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論